Chapter/Section Purchase

1 Oncology Therapeutic Drug Market Overview
1.1 Product Overview and Scope of Oncology Therapeutic Drug
1.2 Oncology Therapeutic Drug Segment by Type
1.2.1 Global Oncology Therapeutic Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Oncology Therapeutic Drug Segment by Application
1.3.1 Global Oncology Therapeutic Drug Sales Comparison by Application: (2022-2028)
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory and Lung Cancer
1.3.6 Others
1.4 Global Oncology Therapeutic Drug Market Size Estimates and Forecasts
1.4.1 Global Oncology Therapeutic Drug Revenue 2017-2028
1.4.2 Global Oncology Therapeutic Drug Sales 2017-2028
1.4.3 Oncology Therapeutic Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oncology Therapeutic Drug Market Competition by Manufacturers
2.1 Global Oncology Therapeutic Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Oncology Therapeutic Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Oncology Therapeutic Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Oncology Therapeutic Drug Manufacturing Sites, Area Served, Product Type
2.5 Oncology Therapeutic Drug Market Competitive Situation and Trends
2.5.1 Oncology Therapeutic Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oncology Therapeutic Drug Players Market Share by Revenue
2.5.3 Global Oncology Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology Therapeutic Drug Retrospective Market Scenario by Region
3.1 Global Oncology Therapeutic Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Oncology Therapeutic Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Oncology Therapeutic Drug Market Facts & Figures by Country
3.3.1 North America Oncology Therapeutic Drug Sales by Country
3.3.2 North America Oncology Therapeutic Drug Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Oncology Therapeutic Drug Market Facts & Figures by Country
3.4.1 Europe Oncology Therapeutic Drug Sales by Country
3.4.2 Europe Oncology Therapeutic Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oncology Therapeutic Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Oncology Therapeutic Drug Sales by Region
3.5.2 Asia Pacific Oncology Therapeutic Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Oncology Therapeutic Drug Market Facts & Figures by Country
3.6.1 Latin America Oncology Therapeutic Drug Sales by Country
3.6.2 Latin America Oncology Therapeutic Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Oncology Therapeutic Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Oncology Therapeutic Drug Sales by Country
3.7.2 Middle East and Africa Oncology Therapeutic Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oncology Therapeutic Drug Historic Market Analysis by Type
4.1 Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
4.2 Global Oncology Therapeutic Drug Revenue Market Share by Type (2017-2022)
4.3 Global Oncology Therapeutic Drug Price by Type (2017-2022)
5 Global Oncology Therapeutic Drug Historic Market Analysis by Application
5.1 Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
5.2 Global Oncology Therapeutic Drug Revenue Market Share by Application (2017-2022)
5.3 Global Oncology Therapeutic Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AbbVie Oncology Therapeutic Drug Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Amgen Oncology Therapeutic Drug Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Astellas Pharma
6.3.1 Astellas Pharma Corporation Information
6.3.2 Astellas Pharma Description and Business Overview
6.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Astellas Pharma Oncology Therapeutic Drug Product Portfolio
6.3.5 Astellas Pharma Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AstraZeneca Oncology Therapeutic Drug Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Bayer Oncology Therapeutic Drug Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Biogen
6.6.1 Biogen Corporation Information
6.6.2 Biogen Description and Business Overview
6.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Biogen Oncology Therapeutic Drug Product Portfolio
6.6.5 Biogen Recent Developments/Updates
6.7 Bristol Myers Squibb
6.6.1 Bristol Myers Squibb Corporation Information
6.6.2 Bristol Myers Squibb Description and Business Overview
6.6.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bristol Myers Squibb Oncology Therapeutic Drug Product Portfolio
6.7.5 Bristol Myers Squibb Recent Developments/Updates
6.8 Celgene
6.8.1 Celgene Corporation Information
6.8.2 Celgene Description and Business Overview
6.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Celgene Oncology Therapeutic Drug Product Portfolio
6.8.5 Celgene Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Corporation Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Eisai Oncology Therapeutic Drug Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Eli Lilly and Company
6.10.1 Eli Lilly and Company Corporation Information
6.10.2 Eli Lilly and Company Description and Business Overview
6.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Eli Lilly and Company Oncology Therapeutic Drug Product Portfolio
6.10.5 Eli Lilly and Company Recent Developments/Updates
6.11 Gilead Sciences
6.11.1 Gilead Sciences Corporation Information
6.11.2 Gilead Sciences Oncology Therapeutic Drug Description and Business Overview
6.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Gilead Sciences Oncology Therapeutic Drug Product Portfolio
6.11.5 Gilead Sciences Recent Developments/Updates
6.12 Ipsen
6.12.1 Ipsen Corporation Information
6.12.2 Ipsen Oncology Therapeutic Drug Description and Business Overview
6.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Ipsen Oncology Therapeutic Drug Product Portfolio
6.12.5 Ipsen Recent Developments/Updates
6.13 Johnson and Johnson
6.13.1 Johnson and Johnson Corporation Information
6.13.2 Johnson and Johnson Oncology Therapeutic Drug Description and Business Overview
6.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Johnson and Johnson Oncology Therapeutic Drug Product Portfolio
6.13.5 Johnson and Johnson Recent Developments/Updates
6.14 Merck
6.14.1 Merck Corporation Information
6.14.2 Merck Oncology Therapeutic Drug Description and Business Overview
6.14.3 Merck Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Merck Oncology Therapeutic Drug Product Portfolio
6.14.5 Merck Recent Developments/Updates
6.15 Novartis
6.15.1 Novartis Corporation Information
6.15.2 Novartis Oncology Therapeutic Drug Description and Business Overview
6.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Novartis Oncology Therapeutic Drug Product Portfolio
6.15.5 Novartis Recent Developments/Updates
6.16 Otsuka Pharmaceutical
6.16.1 Otsuka Pharmaceutical Corporation Information
6.16.2 Otsuka Pharmaceutical Oncology Therapeutic Drug Description and Business Overview
6.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Otsuka Pharmaceutical Oncology Therapeutic Drug Product Portfolio
6.16.5 Otsuka Pharmaceutical Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Oncology Therapeutic Drug Description and Business Overview
6.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Pfizer Oncology Therapeutic Drug Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
6.18 F. Hoffmann-La Roche
6.18.1 F. Hoffmann-La Roche Corporation Information
6.18.2 F. Hoffmann-La Roche Oncology Therapeutic Drug Description and Business Overview
6.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.18.4 F. Hoffmann-La Roche Oncology Therapeutic Drug Product Portfolio
6.18.5 F. Hoffmann-La Roche Recent Developments/Updates
6.19 Sanofi
6.19.1 Sanofi Corporation Information
6.19.2 Sanofi Oncology Therapeutic Drug Description and Business Overview
6.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Sanofi Oncology Therapeutic Drug Product Portfolio
6.19.5 Sanofi Recent Developments/Updates
6.20 Takeda Pharmaceutical
6.20.1 Takeda Pharmaceutical Corporation Information
6.20.2 Takeda Pharmaceutical Oncology Therapeutic Drug Description and Business Overview
6.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Takeda Pharmaceutical Oncology Therapeutic Drug Product Portfolio
6.20.5 Takeda Pharmaceutical Recent Developments/Updates
6.21 Teva Pharmaceutical Industries
6.21.1 Teva Pharmaceutical Industries Corporation Information
6.21.2 Teva Pharmaceutical Industries Oncology Therapeutic Drug Description and Business Overview
6.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Portfolio
6.21.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Oncology Therapeutic Drug Manufacturing Cost Analysis
7.1 Oncology Therapeutic Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oncology Therapeutic Drug
7.4 Oncology Therapeutic Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oncology Therapeutic Drug Distributors List
8.3 Oncology Therapeutic Drug Customers
9 Oncology Therapeutic Drug Market Dynamics
9.1 Oncology Therapeutic Drug Industry Trends
9.2 Oncology Therapeutic Drug Market Drivers
9.3 Oncology Therapeutic Drug Market Challenges
9.4 Oncology Therapeutic Drug Market Restraints
10 Global Market Forecast
10.1 Oncology Therapeutic Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oncology Therapeutic Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Type (2023-2028)
10.2 Oncology Therapeutic Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oncology Therapeutic Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Application (2023-2028)
10.3 Oncology Therapeutic Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oncology Therapeutic Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Oncology Therapeutic Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer